Ligand Pharmaceuticals Incorporated
Ownership
Ownership Structure
Who owns Ligand Pharmaceuticals Incorporated (LGND)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 97.8% of the shares are freely tradable; institutional investors hold 106.4%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 15.56 | 3,100,996 | +4.7 | 06/30/2026 |
| Amvescap Plc. | 6.03 | 1,201,644 | +45.9 | 06/30/2026 |
| Vanguard Portfolio Management, LLC | 5.71 | 1,138,316 | +3.5 | 06/30/2026 |
| Jupiter Topco LLC | 5.22 | 1,040,578 | +0.0 | 06/30/2026 |
| HHG PLC | 5.07 | 1,009,891 | +1.5 | 03/31/2026 |
| Vanguard Capital Management, LLC | 4.37 | 870,950 | +2.7 | 06/30/2026 |
| State Street Corp | 4.15 | 826,539 | +6.1 | 06/30/2026 |
| FMR Inc | 3.83 | 762,827 | +28.0 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 5.96 | 1,187,510 | +0.0 | 09/30/2026 |
| Fidelity Contrafund | 5.28 | 1,052,238 | +0.0 | 08/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Reardon Andrew | CLO & Secretary | 31,854 | 10,282,471 $ | Oct 2, 2026 | direct |
| Espinoza Octavio | Chief Financial Officer | 27,696 | 8,940,269 $ | Aug 12, 2026 | direct |
| Haas Jason | Director | 3,981 | 1,285,067 $ | Aug 12, 2026 | direct |
| Zimmermann Martine | Director | 3,782 | 1,220,830 $ | Sep 22, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 2, 2026 | Reardon Andrew | CLO & Secretary | Sell | 17 | 307.74 | 5,232 |
| Oct 2, 2026 | Reardon Andrew | CLO & Secretary | Sell | 235 | 307.19 | 72,190 |
| Oct 2, 2026 | Reardon Andrew | CLO & Secretary | Sell | 404 | 306.18 | 123,698 |
| Oct 2, 2026 | Reardon Andrew | CLO & Secretary | Sell | 1,535 | 304.52 | 467,431 |
| Oct 2, 2026 | Reardon Andrew | CLO & Secretary | Sell | 1,976 | 303.54 | 599,804 |
| Oct 2, 2026 | Reardon Andrew | CLO & Secretary | Sell | 833 | 302.51 | 251,991 |
| Oct 2, 2026 | Reardon Andrew | CLO & Secretary | Other | 340 | 52.27 | 17,772 |
| Sep 22, 2026 | Zimmermann Martine | Director | Other | 115 | 298.50 | 34,328 |
| Sep 10, 2026 | Zimmermann Martine | Director | Sell | 1,200 | 285.00 | 342,000 |
| Sep 3, 2026 | Reardon Andrew | CLO & Secretary | Sell | 400 | 288.98 | 115,592 |
| Sep 3, 2026 | Reardon Andrew | CLO & Secretary | Sell | 385 | 287.53 | 110,697 |
| Sep 3, 2026 | Reardon Andrew | CLO & Secretary | Sell | 2,115 | 286.36 | 605,649 |
| Sep 3, 2026 | Reardon Andrew | CLO & Secretary | Sell | 1,800 | 285.17 | 513,301 |
| Sep 3, 2026 | Reardon Andrew | CLO & Secretary | Sell | 300 | 283.99 | 85,196 |
| Aug 12, 2026 | Espinoza Octavio | Chief Financial Officer | Sell | 31,641 | 292.07 | 9,241,229 |
| Aug 12, 2026 | Espinoza Octavio | Chief Financial Officer | Other | 3,348 | 68.74 | 230,142 |
| Aug 12, 2026 | Espinoza Octavio | Chief Financial Officer | Other | 7,171 | 57.22 | 410,325 |
| Aug 12, 2026 | Espinoza Octavio | Chief Financial Officer | Other | 2,869 | 55.75 | 159,947 |
| Aug 12, 2026 | Espinoza Octavio | Chief Financial Officer | Other | 2,074 | 70.04 | 145,263 |
| Aug 12, 2026 | Espinoza Octavio | Chief Financial Officer | Other | 16,179 | 52.84 | 854,898 |
| Aug 12, 2026 | Haas Jason | Director | Sell | 7,138 | 292.81 | 2,090,062 |
| Aug 12, 2026 | Haas Jason | Director | Other | 6,138 | 51.56 | 316,475 |
| Aug 3, 2026 | Reardon Andrew | CLO & Secretary | Sell | 409 | 292.82 | 119,763 |
| Aug 3, 2026 | Reardon Andrew | CLO & Secretary | Sell | 991 | 291.71 | 289,086 |
| Aug 3, 2026 | Reardon Andrew | CLO & Secretary | Sell | 200 | 290.60 | 58,120 |
| Aug 3, 2026 | Reardon Andrew | CLO & Secretary | Sell | 503 | 289.80 | 145,771 |
| Aug 3, 2026 | Reardon Andrew | CLO & Secretary | Sell | 356 | 288.75 | 102,795 |
| Aug 3, 2026 | Reardon Andrew | CLO & Secretary | Sell | 1,214 | 287.77 | 349,357 |
| Aug 3, 2026 | Reardon Andrew | CLO & Secretary | Sell | 1,032 | 286.80 | 295,974 |
| Aug 3, 2026 | Reardon Andrew | CLO & Secretary | Sell | 157 | 285.74 | 44,861 |
| Aug 3, 2026 | Reardon Andrew | CLO & Secretary | Sell | 33 | 284.55 | 9,390 |
| Aug 3, 2026 | Reardon Andrew | CLO & Secretary | Sell | 105 | 284.14 | 29,834 |
| Aug 3, 2026 | Reardon Andrew | CLO & Secretary | Other | 5,000 | 52.27 | 261,350 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.